
Hemogenix
Colorado Springs, CO, United States hemogenix.com From their website, Nov 2026
- GLP
Work here? Claim this listing
About
HemoGenix provides contract research services focused on in vitro toxicology, cell-based assays, and potency testing for biopharmaceutical, cellular therapy, and regenerative medicine clients. It works with primary cells, human tissue, animal tissues, and tumor cells to assess toxicity, mechanism of action, and product quality. The company is based in Colorado Springs, Colorado.
Services
High-throughput screening
Performs high-throughput screening using primary cell systems, cell lines, and tumor cells for comparative toxicity screening and compound ranking.
Stem cell toxicity
Evaluates toxicity in stem cell systems, including stem cell hematotoxicity and related biology.
Bone marrow toxicity and stem cell hematotoxicity
Assesses toxicity effects on bone marrow and hematopoietic stem cell systems.
Immunotoxicity
Tests compounds for effects on the immune system using in vitro assay platforms.
Mesenchymal cell toxicity
Measures toxic effects in mesenchymal cell systems.
Hepatotoxicity
Assesses liver toxicity in in vitro models.
Cardiotoxicity
Assesses heart-related toxicity using cell-based assays.
Neurotoxicity
Assesses nervous system toxicity in in vitro models.
12 more services
- Renal toxicity
- Skin toxicity
- Intestinal toxicity
- Genotoxicity
- Nanoparticle toxicity panel testing
- Mechanism of Action (MOA)
- Drug-drug interaction and combination therapy
- Biologics, small molecule and drug functionality and potency testing
- Stem cell potency and quality testing for cellular therapeutics
- Customized basic research on several biological systems
- Cell-based assay services
- IND-enabling assays
- Turnaround
- Most in vitro studies are completed within 7-14 days.
- Phase I Report is usually provided within 5 - 7 business days after study completion.
Capabilities
- Assays and studies
- Cell-based assays
- HTS
- In vivo
- Cell therapy
- Rodent models
- Toxicology
16 more
- Small molecules
- Hematotoxicity
- Immunotoxicity
- Mesenchymal stem cell toxicity
- Hepatotoxicity
- Cardiotoxicity
- Neurotoxicity
- Renal toxicity
- Skin toxicity
- Intestinal toxicity
- Genotoxicity
- Drug interaction
- Combination therapy
- Mechanism of action
- Potency assay
- Quality assay
- Therapeutic areas
- Cell therapy
- Regenerative medicine
Modalities and species
- Modalities
- Small molecule
- Cell therapy
- Species and models
- Primate
- Minipig
- Dog
- Rat
- Mouse
- Human tissue
9 more
- Primary cells
- Cryopreserved primary cells
- Tumor cells
- Bone marrow
- Umbilical cord blood
- Peripheral blood
- CD34+ cells
- CD133+ cells
- Mesenchymal stem/stromal cells
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Scope: Customized, full-service studies
Details
- Type
- CRO
- Founded
- 2000
- Based in
- Colorado Springs, CO, United States
- Serves
- World-wide